Volition logo logo
Nu.Q® Discover epigenetic profiling for target identification to validation in clinical studies

Nu.Q® Discover White Paper: The epigenetic keys to unlocking…

Blog
Larger beagle image

London Vet Show 2023: Volition Veterinary Highlights.

Blog
SAB 22

Scientific Advisory Board Update

Blog
Voilition_2306202558

Meet Ben Berman

Blog
Remi Rabeuf

Meet Remi Rabeuf

Blog
Netosis illustration

Genomeweb to Host Volition Webinar on Neutrophils.

Blog

Subscribe for Volition product updates.

Or, click here for Investor Updates and press releases

volition-nets-4

Early cancer detection by plasma CTCF transcription factor a…

Blog
volition-news

Nu.Q® NETs: New sepsis study at Guy’s & St Thomas…

Blog
At Work A_High res

Meet Marielle Herzog, our R&D Director

Blog
Volition_231115_0136

Volition Business Review 2023

Blog
Volition - NETs infographic 031022 FINAL-1

Learn about NETs, NETosis and Nu.Q® NETs.

Blog
Volition 230619

Volition’s collaboration with Professor Lea Payen and …

Blog
Volition scientist packing Nu.Q test

Scaling Up for Success: Volition Partners with IVD Research …

Blog
Women in science day 2022 crop

Celebrating International Day of Women and Girls in Science.

Blog
Gaetan Michel

Meet Gaetan Michel

Blog
Cameron Reynolds, President & Group CEO of Volition

Volition Business Review 2022

Blog
SAB 22

Our Scientific Advisory Board meeting 2022

Blog
Jasmine Kway

A spotlight on Volition’s Asia Strategy.

Blog
Volition_231115_0284

A spotlight on…Volition’s Commercialisation Stra…

Blog
Sharon_Ballesteros 2022

A spotlight on… Volition’s U.S. Clinical Product…

Blog
volition-veterinarians-1

Volition to Host Second Genomeweb Webinar.

Blog
DSC_0734

Volition Opens New Innovation Hub.

Blog
Volition advert 1

Epigenetic cancer tests for both ends of the leash.

Blog
Tom Butera

Meet Tom Butera

Blog
TERRY_HEADSHOT_02

Meet Terry Kelly

Blog
Volitionrx_2391_HR

Business Review 2021

Blog